| Pancreatic cancer A Vincent, J Herman, R Schulick, RH Hruban, M Goggins The lancet 378 (9791), 607-620, 2011 | 3230 | 2011 |
| DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer CA Iacobuzio-Donahue, B Fu, S Yachida, M Luo, H Abe, CM Henderson, ... Journal of clinical oncology 27 (11), 1806-1813, 2009 | 1195 | 2009 |
| Recent progress in pancreatic cancer CL Wolfgang, JM Herman, DA Laheru, AP Klein, MA Erdek, EK Fishman, ... CA: a cancer journal for clinicians 63 (5), 318-348, 2013 | 1142 | 2013 |
| Pancreatic adenocarcinoma, version 2.2017, NCCN clinical practice guidelines in oncology MA Tempero, MP Malafa, M Al-Hawary, H Asbun, A Bain, SW Behrman, ... Journal of the National Comprehensive Cancer Network 15 (8), 1028-1061, 2017 | 1020 | 2017 |
| Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network E Collisson, J Campbell, A Brooks, A Berger, W Lee, J Chmielecki, D Beer, ... Nature 511 (7511), 543-550, 2014 | 870 | 2014 |
| Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma P Peng, O Hyder, A Firoozmand, P Kneuertz, RD Schulick, D Huang, ... Journal of gastrointestinal surgery 16 (8), 1478-1486, 2012 | 576 | 2012 |
| Phase 2 multi‐institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma JM Herman, DT Chang, KA Goodman, AS Dholakia, SP Raman, ... Cancer 121 (7), 1128-1137, 2015 | 524 | 2015 |
| Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies H Haeno, M Gonen, MB Davis, JM Herman, CA Iacobuzio-Donahue, ... Cell 148 (1), 362-375, 2012 | 479 | 2012 |
| Preoperative modified FOLFIRINOX treatment followed by capecitabine-based chemoradiation for borderline resectable pancreatic cancer: alliance for clinical trials in oncology … MHG Katz, Q Shi, SA Ahmad, JM Herman, RW Marsh, E Collisson, ... JAMA surgery 151 (8), e161137-e161137, 2016 | 457 | 2016 |
| SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer A Blackford, OK Serrano, CL Wolfgang, G Parmigiani, S Jones, X Zhang, ... Clinical cancer research 15 (14), 4674-4679, 2009 | 448 | 2009 |
| A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma: a phase II trial of safety, efficacy … L Eric, CJ Yeo, KD Lillemoe, B Biedrzycki, B Kobrin, J Herman, E Sugar, ... Annals of surgery 253 (2), 328-335, 2011 | 443 | 2011 |
| Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis MB Slidell, DC Chang, JL Cameron, C Wolfgang, JM Herman, ... Annals of surgical oncology 15, 165-174, 2008 | 443 | 2008 |
| Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively … JM Herman, MJ Swartz, CC Hsu, J Winter, TM Pawlik, E Sugar, ... Journal of Clinical Oncology 26 (21), 3503-3510, 2008 | 430 | 2008 |
| Pancreatic adenocarcinoma, version 2.2014 MA Tempero, MP Malafa, SW Behrman, AB Benson, ES Casper, ... Journal of the National Comprehensive Cancer Network 12 (8), 1083-1093, 2014 | 414 | 2014 |
| Locally advanced, unresectable pancreatic cancer: American Society of Clinical Oncology clinical practice guideline EP Balaban, PB Mangu, AA Khorana, MA Shah, S Mukherjee, CH Crane, ... Journal of Clinical Oncology 34 (22), 2654-2668, 2016 | 398 | 2016 |
| Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial design MHG Katz, R Marsh, JM Herman, Q Shi, E Collison, AP Venook, ... Annals of surgical oncology 20, 2787-2795, 2013 | 372 | 2013 |
| Whole genome sequencing defines the genetic heterogeneity of familial pancreatic cancer NJ Roberts, AL Norris, GM Petersen, ML Bondy, R Brand, S Gallinger, ... Cancer discovery 6 (2), 166-175, 2016 | 367 | 2016 |
| Circulating nucleic acids are associated with outcomes of patients with pancreatic cancer V Bernard, DU Kim, FA San Lucas, J Castillo, K Allenson, FC Mulu, ... Gastroenterology 156 (1), 108-118. e4, 2019 | 350 | 2019 |
| Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines MA Tempero, JP Arnoletti, SW Behrman, E Ben-Josef, AB Benson, ... Journal of the National Comprehensive Cancer Network 10 (6), 703-713, 2012 | 344 | 2012 |
| Clinical significance of the genetic landscape of pancreatic cancer and implications for identification of potential long-term survivors S Yachida, CM White, Y Naito, Y Zhong, JA Brosnan, AM Macgregor-Das, ... Clinical Cancer Research 18 (22), 6339-6347, 2012 | 319 | 2012 |
